Literature DB >> 9393679

Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships.

M C Scorza1, C Carrau, R Silveira, G Zapata-Torres, B K Cassels, M Reyes-Parada.   

Abstract

The monoamine oxidase (MAO) inhibitory properties of a series of amphetamine derivatives with different substituents at or around the para position of the aromatic ring were evaluated. In in vitro studies in which a crude rat brain mitochondrial suspension was used as the source of MAO, several compounds showed a strong (IC50 in the submicromolar range), selective, reversible, time-independent, and concentration-related inhibition of MAO-A. After i.p. injection, the compounds induced an increase of serotonin and a decrease of 5-hydroxyindoleacetic acid in the raphe nuclei and hippocampus, confirming the in vitro results. The analysis of structure-activity relationships indicates that: molecules with amphetamine-like structure and different substitutions on the aromatic ring are potentially MAO-A inhibitors; substituents at different positions of the aromatic ring modify the potency but have little influence on the selectivity; substituents at the para position such as amino, alkoxyl, halogens, or alkylthio produce a significant increase in the activity; the para-substituent must be an electron donor; bulky groups next to the para substituent lead to a decrease in the activity; substituents located at positions more distant on the aromatic ring have less influence and, even when the substituent is a halogen (Cl, Br), an increase in the activity of the compound is obtained. Finally, the MAO-A inhibitory properties of some of the compounds evaluated are discussed in relation to: (a) potential antidepressant activity, and (b) their reported hallucinogenic, neurotoxic, or anxiolytic effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393679     DOI: 10.1016/s0006-2952(97)00405-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Charge-transfer interactions in the inhibition of MAO-A by phenylisopropylamines--a QSAR study.

Authors:  Gabriel Vallejos; Marcos Caroli Rezende; Bruce K Cassels
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

2.  The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue.

Authors:  J E Sprague; T J Worst; K Haynes; C R Mosler; D E Nichols; M D Kane
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

Review 3.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 4.  A guide to neurotoxic animal models of Parkinson's disease.

Authors:  Kim Tieu
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

5.  Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.

Authors:  Hiroshi Onogi; Masato Hozumi; Osamu Nakagawasai; Yuichiro Arai; Seiichiro Ishigaki; Atsushi Sato; Seiichi Furuta; Fukie Niijima; Koichi Tan-No; Takeshi Tadano
Journal:  Psychopharmacology (Berl)       Date:  2009-12-04       Impact factor: 4.530

6.  Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse.

Authors:  Helena Carmo; Jan G Hengstler; Douwe de Boer; Michael Ringel; Félix Carvalho; Eduarda Fernandes; Fernando Remião; Lesseps A dos Reys; Franz Oesch; Maria de Lourdes Bastos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-16       Impact factor: 3.000

7.  Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.

Authors:  Alicia J Avelar; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2013-03-06       Impact factor: 5.372

8.  Neurotoxicity of some MAO inhibitors in adult rat hypothalamic cell culture.

Authors:  C Hurtado-Guzmán; P Martínez-Alvarado; A Dagnino-Subiabre; I Paris; P Caviedes; R Caviedes; B K Cassels; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

9.  Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies.

Authors:  Angélica Fierro; Mauricio Osorio-Olivares; Bruce K Cassels; Dale E Edmondson; Silvia Sepúlveda-Boza; Miguel Reyes-Parada
Journal:  Bioorg Med Chem       Date:  2007-05-22       Impact factor: 3.641

10.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Authors:  Mei Cui; Radha Aras; Whitney V Christian; Phillip M Rappold; Mamata Hatwar; Joseph Panza; Vernice Jackson-Lewis; Jonathan A Javitch; Nazzareno Ballatori; Serge Przedborski; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.